Krishan Sivaraj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Krishan Sivaraj has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- John P. Vavalle
Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
2 shared publications - Matthew A. Cavender
University of North Carolina School of Medicine, Chapel Hill
2 shared publications - Michael J. Hendrickson
University of North Carolina Chapel Hill, Chapel Hill, NC
2 shared publications - Sameer Arora
The University of North Carolina at Chapel Hill, United States
2 shared publications - Trisha Slehria
Department of Internal Medicine, University of Iowa Healthcare, Iowa City, Iowa
2 shared publications - Ambarish Pandey
Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
1 shared publication
Latest Publications
- 1 March 2023
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 16 (3) , 270-278
Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study
Background: Few studies characterize the epidemiology and outcomes of aortic stenosis (AS) in acute decompensated heart failure (ADHF). This study investigates the significance of AS in contemporary patients who have experienced an ADHF hospitalization. Methods: The ARIC study (Atherosclerosis Risk in Communities) surveilled ADHF hospitalizations for residents ≥55 years of age in 4 US communities. ADHF cases were stratified by left ventricular ejection fraction (LVEF). Demographic differences in AS burden and the association of varying AS severities with mortality were estimated using multivariable logistic regression. Results: From 2005 through 2014, there were 3597 (weighted n=16 692) ADHF hospitalizations of which 48.6% had an LVEF <50% and 51.4% an LVEF ≥50%. AS prevalence was 12.1% and 18.7% in those with an LVEF <50% and ≥50%, respectively. AS was less likely in Black than White patients regardless of LVEF: LVEF <50% (odds ratio [OR], 0.34 [95% CI, 0.28–0.42]); LVEF ≥50% (OR, 0.51 [95% CI, 0.44–0.59]). Higher AS severity was independently associated with 1-year mortality in both LVEF subgroups: LVEF <50% (OR, 1.16 [95% CI, 1.04–1.28]); LVEF ≥50% (OR, 1.40 [95% CI, 1.28–1.54]). Sensitivity analyses excluding severe AS patients detected that mild/moderate AS was independently associated with 1-year mortality in both LVEF subgroups: LVEF <50% (OR, 1.23 [95% CI, 1.02–1.47]); LVEF ≥50% (OR, 1.31 [95% CI, 1.14–1.51]). Conclusions: Among patients who have experienced an ADHF hospitalization, AS is prevalent and portends poor mortality outcomes. Notably, mild/moderate AS is independently associated with 1-year mortality in this high-risk population.
- 1 March 2023
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 16 (3) , 270-278
Epidemiology and Outcomes of Aortic Stenosis in Acute Decompensated Heart Failure: The ARIC Study
Background: Few studies characterize the epidemiology and outcomes of aortic stenosis (AS) in acute decompensated heart failure (ADHF). This study investigates the significance of AS in contemporary patients who have experienced an ADHF hospitalization. Methods: The ARIC study (Atherosclerosis Risk in Communities) surveilled ADHF hospitalizations for residents ≥55 years of age in 4 US communities. ADHF cases were stratified by left ventricular ejection fraction (LVEF). Demographic differences in AS burden and the association of varying AS severities with mortality were estimated using multivariable logistic regression. Results: From 2005 through 2014, there were 3597 (weighted n=16 692) ADHF hospitalizations of which 48.6% had an LVEF <50% and 51.4% an LVEF ≥50%. AS prevalence was 12.1% and 18.7% in those with an LVEF <50% and ≥50%, respectively. AS was less likely in Black than White patients regardless of LVEF: LVEF <50% (odds ratio [OR], 0.34 [95% CI, 0.28–0.42]); LVEF ≥50% (OR, 0.51 [95% CI, 0.44–0.59]). Higher AS severity was independently associated with 1-year mortality in both LVEF subgroups: LVEF <50% (OR, 1.16 [95% CI, 1.04–1.28]); LVEF ≥50% (OR, 1.40 [95% CI, 1.28–1.54]). Sensitivity analyses excluding severe AS patients detected that mild/moderate AS was independently associated with 1-year mortality in both LVEF subgroups: LVEF <50% (OR, 1.23 [95% CI, 1.02–1.47]); LVEF ≥50% (OR, 1.31 [95% CI, 1.14–1.51]). Conclusions: Among patients who have experienced an ADHF hospitalization, AS is prevalent and portends poor mortality outcomes. Notably, mild/moderate AS is independently associated with 1-year mortality in this high-risk population.
- 13 August 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (8) , e231387
Onychocryptosis and asymptomatic external urethritis as complications of oral isotretinoin therapy
This case report presents a patient who, while undergoing oral isotretinoin therapy for acne vulgaris, developed onychocryptosis and asymptomatic external urethritis. These uncommon adverse events are not well-documented in medical literature. While his urethritis spontaneously resolved, his onychocryptosis symptoms necessitated surgical intervention. This report illustrates both cosmetic and functional adverse effects of isotretinoin and provides insight into the progression of these reactions over time.
- 13 August 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (8) , e231387
Onychocryptosis and asymptomatic external urethritis as complications of oral isotretinoin therapy
This case report presents a patient who, while undergoing oral isotretinoin therapy for acne vulgaris, developed onychocryptosis and asymptomatic external urethritis. These uncommon adverse events are not well-documented in medical literature. While his urethritis spontaneously resolved, his onychocryptosis symptoms necessitated surgical intervention. This report illustrates both cosmetic and functional adverse effects of isotretinoin and provides insight into the progression of these reactions over time.